Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma
4 Ansichten
• 07/18/23
0
0
Einbetten
administrator
Abonnenten
Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare